BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Furusyo N, Takeoka H, Toyoda K, Murata M, Tanabe Y, Kajiwara E, Shimono J, Masumoto A, Maruyama T, Nomura H, Nakamuta M, Takahashi K, Shimoda S, Azuma K, Sakai H, Hayashi J, Group TKULDS. Long-term lamivudine treatment for chronic hepatitis B in Japanese patients: A project of Kyushu University Liver Disease Study. World J Gastroenterol 2006; 12(4): 561-567 [PMID: 16489669 DOI: 10.3748/wjg.v12.i4.561]
URL: https://www.wjgnet.com/1007-9327/full/v12/i4/561.htm
Number Citing Articles
1
Motohiro Shimizu, Norihiro Furusyo, Hiroaki Ikezaki, Eiichi Ogawa, Takeo Hayashi, Takeshi Ihara, Yuji Harada, Kazuhiro Toyoda, Masayuki Murata, Jun Hayashi. Predictors of kidney tubular dysfunction induced by adefovir treatment for chronic hepatitis BWorld Journal of Gastroenterology 2015; 21(7): 2116-2123 doi: 10.3748/wjg.v21.i7.2116
2
Francisco José Dutra Souto, Ana Carolina da Silva Pirajá, Graciana Soares da Silva, Marcelle Bottecchia, Selma Andrade Gomes. Lamivudina por tempo prolongado no tratamento da hepatite B crônica no estado de Mato GrossoRevista da Sociedade Brasileira de Medicina Tropical 2007; 40(1): 18 doi: 10.1590/S0037-86822007000100004
3
Eiichi Ogawa, Norihiro Furusyo, Kazuhiro Toyoda, Hiroaki Takeoka, Shigeru Otaguro, Maki Hamada, Masayuki Murata, Yasunori Sawayama, Jun Hayashi. Transient elastography for patients with chronic hepatitis B and C virus infection: Non‐invasive, quantitative assessment of liver fibrosisHepatology Research 2007; 37(12): 1002 doi: 10.1111/j.1872-034X.2007.00160.x
4
Norihiro Furusyo, Eiji Kajiwara, Kazuhiro Takahashi, Hideyuki Nomura, Yuichi Tanabe, Akihide Masumoto, Toshihiro Maruyama, Makoto Nakamuta, Munechika Enjoji, Koichi Azuma, Junya Shimono, Hironori Sakai, Shinji Shimoda, Jun Hayashi. Association between the treatment length and cumulative dose of pegylated interferon alpha‐2b plus ribavirin and their effectiveness as a combination treatment for Japanese chronic hepatitis C patients: Project of the Kyushu University Liver Disease Study GroupJournal of Gastroenterology and Hepatology 2008; 23(7pt1): 1094 doi: 10.1111/j.1440-1746.2008.05319.x
5
Yuhai Zhang, Haixia Su, Lei Shang, Duan Li, Rui Wang, Ruiqiao Zhang, Yongyong Xu. Preferences and Perceived Involvement in Treatment Decision Making among Chinese Patients with Chronic HepatitisMedical Decision Making 2011; 31(2): 245 doi: 10.1177/0272989X10375990
6
Eiichi Ogawa, Norihiro Furusyo, Masayuki Murata, Hachiro Ohnishi, Kazuhiro Toyoda, Hiroaki Taniai, Takeshi Ihara, Hiroaki Ikezaki, Takeo Hayashi, Mosaburo Kainuma, Jun Hayashi. Longitudinal assessment of liver stiffness by transient elastography for chronic hepatitis B patients treated with nucleoside analogHepatology Research 2011; 41(12): 1178 doi: 10.1111/j.1872-034X.2011.00869.x
7
Feng Wu, Min-Jin Wu, Xiao-Lin Zhuge, Shao-Ming Zhu, Biao Zhu. Correlation of the occurrence of YMDD mutations with HBV genotypes, HBV-DNA levels, and HBeAg status in Chinese patients with chronic hepatitis B during lamivudine treatmentHepatobiliary & Pancreatic Diseases International 2012; 11(2): 172 doi: 10.1016/S1499-3872(12)60144-1